The company Biontech is examining whether it can deliver more vaccine against the coronavirus than previously agreed.
"We are currently checking whether and, if so, how many doses we could deliver at short notice and in addition to the contractually agreed ones," said Biontech spokeswoman Jasmina Alatovic of the German press agency in Mainz.
Mainz - In a letter to the federal states, the Federal Ministry of Health announced restrictions on order quantities for the Biontech vaccine for the next few weeks.
To this end, the preparation from Moderna is to be used more frequently for booster vaccinations.
As a justification, reference was also made to the fact that otherwise from the middle of the 1st quarter of 2022 stored Moderna cans threatened to expire.
Biontech's vaccine currently accounts for over 90 percent of orders.
dpa